An interventional study of Yogatherapy and Physiotherapy in Axial Spondyloarthritis (axSPA), sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.
Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Axial Spondyloarthritis with a site in France — 9 open to participants now, 11 under way, 3 of them phase 3. Axial Spondyloarthritis · France.
Among the 40 studies in Axial Spondyloarthritis with a site in France, this one is the 24th largest by planned enrollment of the 30 interventional ones that give a count, is one of 4 that started in 2024, is one of 13 with no phase, reaches primary completion later than 7 of the 10 other live ones, and was the 35th registered.
187 studies on the registry are indexed under Axial Spondyloarthritis; 57 are open to participants now.
Browse Axial Spondyloarthritis studies →9 of the 40 studies in Axial Spondyloarthritis with a site in France are open now. Recruiting first, the newest first:
University Hospital, Strasbourg, France · Sites in France
Ages 18+
Association de Recherche Clinique en Rhumatologie · Sites in France
Ages 18–80
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–75
Centre Hospitalier Universitaire de Besancon · Sites in France
Ages 18–80
Centre Hospitalier Universitaire de Besancon · Sites in France
Ages 18–80
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 39 Axial Spondyloarthritis studies recruiting now, 20 (51%) set no upper age limit and 13 (33%) stop at 75 or younger; 5 take children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 1 · Phase 3 13 · Phase 4 2
First in 2009; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 72 is below the median of 106 across 123 interventional studies indexed under Axial Spondyloarthritis.
Median enrollment 188 across the 30 interventional studies, 413 across the 10 observational. Of the 27 that completed or were terminated, 12 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 40 have an industry lead sponsor. The 10 most frequent:
Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.
Assistance Publique - Hôpitaux de Paris has 7 studies filed under Axial Spondyloarthritis — fewer than ten, so there is no comparison to draw.
4 of the studies in Axial Spondyloarthritis with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05654753Phase 3Assistance Publique - Hôpitaux de ParisThe Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment | 2027-09 |
| NCT06259890Centre Hospitalier Universitaire de BesanconInfluence of Sodium Intake in spondyLoarthriTes | 2026-11 |
| NCT04286373Assistance Publique - Hôpitaux de ParisEfficacy of Non-invasive Vagus Nerve Stimulation for Axial Spondyloarthritis Resistant to Biotherapies | 2026-12 |
| NCT07141017Association de Recherche Clinique en RhumatologieInitial Standardized Global Review in Axial Spondyloarthritis | 2027-05 |
Add all 4 to your calendar (.ics) → With an account.
Among the 40 studies in Axial Spondyloarthritis with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A few studies have evaluated the effectiveness of yoga therapy in patients with axial spondyloarthritis (axSPA). On the other hand, studies conducted in other chronic rheumatisms such as low back pain, rheumatoid arthritis or other conditions such as cancer have shown that yogatherapy can have a effective action on the physical and psychological level.
Yogatherapy is a non-drug "body-mind" approach that would be likely to improve the physical symptoms (pain, stiffness, in particular spinal and pelvic), internal organs (colitis) and psychological symptoms as well as the perception of fatigue of people with axSPA. A 2021 study showed the feasibility and acceptability of regular yogatherapy practice in patients with axSPA.
It is therefore necessary to conduct randomized controlled studies to assess the effectiveness of this management strategy.
The term axial spondyloarthritis (axSPA) encompasses various inflammatory diseases of the spine, including ankylosing spondyloarthritis (AS) and non-radiographic axial spondyloarthritis (nr-axSPA).
axSPA is a chronic inflammatory joint disease affecting the axial skeleton. It is the second cause of chronic inflammatory rheumatism and affects 0.5 to 2% of the general population. It generally affects young adults, with a male predominance (2 men for 1 woman).
axSPA can lead to physical consequences (fatigue, pain, stiffness, with in particular serious damage to the spine causing functional impairment, etc.) and psychological consequences (anxiety, depression). It is responsible for a disability and a mediocre quality of life with, moreover, a significant socio-economic impact. In France, it is one of the long-term illnesses and may require heavy treatment.
The medicinal therapeutic side, taken care of by rheumatologists specializing in this pathology, has evolved a lot (from non-steroidal anti-inflammatory drugs [NSAIDs] to anti-tumor necrosis factor [anti-TNF] and anti-interleukin 17 [anti-IL 17]), allowing notable improvements. It is now a question of also developing the non-drug therapeutic side, to contribute to improving the quality of life, thus meeting the demand of patients with chronic diseases.
Information and therapeutic education occupy an important place, with results in favor of an improvement in the management of these diseases.
The recommendations emphasize that the non-pharmacological treatment of axSPA should include regular physical exercise, that individual and group physical therapy sessions should be considered as well as self-exercises.
Several randomized controlled trials have shown that physical therapy with various modalities has positive effects on pain and AS function. Physical therapy therefore also seems to play an important role in the management of patients. It prevents stiffness and improves functional capacity and quality of life.
Physical therapy should be initiated as soon as axSPA is diagnosed and regular exercise should form the basis of management. The review by Zochling et al. as well as a systematic review showed that exercises have positive effects on BASFI, BASDAI functions, pain and mobility. A Cochrane review on the role of physiotherapy interventions in SPA also concluded that physical therapy was beneficial. Physical activity, self-exercises and physiotherapy are part of the 2022 recommendations of the French Society of Rheumatology. Beneficial effects on disease activity were observed in axSPA, with good tolerance for intense exercise.
Recently an Indian team evaluated the effectiveness of online yogatherapy with 60 min structured modules on patients with axSPA for 3 months, with a significant improvement in the BASDAI score.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Randomization of 36 patients in the yogatherapy group.
Procedure: Yogatherapy
Randomization of 36 patients in the physiotherapy group.
Procedure: Physiotherapy
The experimental arm will benefit from support by a physiotherapist trained in yoga, in a group for ten weeks with two weekly sessions of approximately 1 hour each. A new yoga program adapted for the axSPA will be implemented.
The comparator arm will benefit from support by a physiotherapist, in groups for ten weeks at the rate of two weekly sessions of approximately 1 hour each. An already existing program adapted for the axSPA will be implemented.
Evolution of the axSPA global activity score (fatigue, pain, stiffness)
Change in the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) score, via a self-administered questionnaire that assesses the "activity" of the disease (6 items, max score = 100, the higher the score the more disabling the disease).
Time frame: Between the 2 month visit and the 5 month visit.
Evolution of the axSPA global activity score (fatigue, pain, stiffness)
Change in the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) score, via a self-administered questionnaire that assesses the "activity" of the disease (6 items, max score = 100, the higher the score the more disabling the disease).
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Functional impact
Change in self-assessment of functional capacity during daily tasks via the BASFI score (Bath Ankylosing Spondylitis disease Functional Index) (10 items, max score = 10, the higher the score the more disabling the disease).
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Health-related quality of life
Change in the patient's self-assessment via the generic SF-36 scale (Short Form-36 scale) (36 items, max score = 100, the higher the score the better the perception of quality of life).
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Anxiety and depression
Change in the patient's self-assessment via the HAD scale (Hospital Anxiety and Depression scale) (14 items, max anxiety score = 21, max depression score = 21, the higher the score the more anxiety and depressive disorders are marked).
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Respiratory capacity
Measurement of chest expansion.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Spinal and axial mobility (maximum active amplitudes - sagittal plane)
Change in measurement of maximum active amplitudes in orthostatism of the thoraco-lumbar spine in the sagittal (flexion/extension) plane.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Spinal and axial mobility (degrees of kyphosis and lordosis)
Change in measurement of the degrees of kyphosis and lordosis while standing.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Spinal and axial mobility (maximum active amplitudes - frontal plane)
Change in measurement of maximum active amplitudes in orthostatism of the thoraco-lumbar spine in the frontal (lateral inclinations) plane.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Spinal and axial mobility (podobarometric treadmill)
Change in measurement of the spatiotemporal analysis of gait on a podobarometric treadmill.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Axial mobility
Change in BASMI (Bath Ankylosing Spondylitis Metrology Index) score (5 items, max score = 10, the higher the score the more restricted the axial mobility).
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Follow-up of the therapeutic strategy
Change in therapeutic strategy.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Drug consumption monitoring
Change in drug consumption.
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Sleep quality
Change in QESL score (Leeds Sleep Assessment Questionnaire) (10 visual analog scales, minimum = -50, maximum = 50, the higher the score the better the sleep).
Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.
Adherence to the practice of yogatherapy of patients randomized in this group
Degree of adherence to the practice of yogatherapy collected through responses to a short self-questionnaire.
Time frame: After physical rehabilitation : at 5 month and 11 month visits.
Not enrolling at this site.
Not enrolling at this site.
Plan to share: No — Datas are own by Assistance Publique - Hôpitaux de Paris, please contact sponsor for further information.
No publications or documents are linked to this record.
Started Aug 2024 (actual). Primary completion is estimated for Feb 2028, 41 months after the start.
Of 46 non-industry interventional studies with no phase under Axial Spondyloarthritis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 42. This study's planned 41 months is above that.
Counting every sponsor, half of 46 studies reached it within 28 months; a quarter within 11 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →